Tags: EU | Britain | Opioid

Reckitt Benckiser Pays $1.4 Billion in Opioid Settlement

Thursday, 11 July 2019 12:38 PM

LONDON (AP) — Consumer products company Reckitt Benckiser says it will pay $1.4 billion to resolve U.S. investigations into the marketing of an anti-addiction drug by a subsidiary.

The company said Thursday it reached agreements with the U.S. Department of Justice and the Federal Trade Commission.

The government alleged that an ex-Reckitt subsidiary sought to increase prescriptions for Suboxone Film by deceiving health care providers into believing the drug was safer than other opioid addiction treatments.

Suboxone Film was marketed by RB's former prescription business Indivior, which was spun off in 2014.

The company says it "acted lawfully at all times and expressly denies all allegations that it engaged in any wrongful conduct" but the settlement was in the best interest of RB and shareholders.

It said the settlement would prevent uncertainty and distraction from continued investigations.

© Copyright 2019 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

   
1Like our page
2Share
GlobalTalk
Consumer products company Reckitt Benckiser says it will pay $1.4 billion to resolve U.S. investigations into the marketing of an anti-addiction drug by a subsidiary.The company said Thursday it reached agreements with the U.S. Department of Justice and the Federal Trade...
EU,Britain,Opioid
136
2019-38-11
Thursday, 11 July 2019 12:38 PM
Newsmax Media, Inc.
 
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved